Current Opinion in Lipidology

Papers
(The H4-Index of Current Opinion in Lipidology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Regulation of lipoprotein lipase-mediated lipolysis of triglycerides65
Remnant lipoproteins: are they equal to or more atherogenic than LDL?55
Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease43
Genetic, biochemical, and clinical features of LCAT deficiency: update for 202036
Apolipoprotein C-II: the re-emergence of a forgotten factor33
ANGPTL3 as therapeutic target33
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis29
Familial combined hypolipidemia: angiopoietin-like protein-3 deficiency28
Mendelian randomization as a tool for causal inference in human nutrition and metabolism28
The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?28
Tangier disease: update for 202027
Hypertriglyceridemia: new approaches in management and treatment26
Very long-chain saturated fatty acids and diabetes and cardiovascular disease26
Update on apolipoprotein B25
Impact of ultra-processed food consumption on metabolic health24
Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence23
Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia22
Autosomal recessive hypercholesterolemia: update for 202022
Lipids and peripheral neuropathy21
Management of familial hypercholesterolemia in pregnancy20
0.01825213432312